SCHEMBL21065262

SCHEMBL21065262

CCC1(C(=O)O)CC(c2ccc(OC)cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
GAA P10253 2/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
DRD2 P14416 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 3/20 0.40
EDNRA P25101 2/20 0.40
EDNRB P24530 1/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 2/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MEN1 O00255 2/20 0.39
GUSB P08236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21065268 0.83 ESR2 (0.41) ALDH1A1KDM4ESMN1; SMN2TSHR
SCHEMBL21065308 0.81 KDM1A (0.44) LMNARAB9AHSD11B1
SCHEMBL31154440 0.81 DRD2 (0.43) ALDH1A1GAALMNAKDM4EHPGD
SCHEMBL31154439 0.81 DRD2 (0.43) ALDH1A1GAALMNAKDM4EHPGD
SCHEMBL7969814 0.78 KDM1A (0.48) TSHR
SCHEMBL7070199 0.76 KMT2A (0.45) ALDH1A1GAALMNAKDM4EHPGD
SCHEMBL31414038 0.74 MEN1 (0.49) ALDH1A1LMNAKDM4EHPGDSMN1; SMN2
SCHEMBL26104884 0.74 CYP2C19 (0.47) ALDH1A1GAAKDM4ESMN1; SMN2KMT2A
Bicarbonate SCHEMBL6207408 0.73 ALDH1A1 (0.52) ALDH1A1LMNAKDM4EHPGDDRD2
SCHEMBL31154380 0.72 SMN1; SMN2 (0.42) ALDH1A1GAAKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068785-B1 SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-06-26 EP disclosed